Cristian Perra
Transient inflammation in surgical scars following Covid-19 mRNA vaccination
Ferreli, CPrimo
Writing – Original Draft Preparation
;Anedda, JData Curation
;Atzori, L
Ultimo
Writing – Review & Editing
2022-01-01
Abstract
The current coronavirus disease 2019 pandemic has exceeded any epidemiologic prevision, but increasing information suggests some analogies with the major viral outbreaks in the last century, and a general warning has been issued on the possibility that coinfections can make the differential diagnosis and treatment difficult, especially in tropical countries. Some reports have noted that the presence of high dengue antibodies can give a false-negative result when testing for severe acute respiratory syndrome coronavirus 2. Mucocutaneous manifestations are very frequent, with an apparent overlap among different pathogens. However, strong clinicopathologic correlation might provide some clues to address differentials. Waiting for laboratory and instrumental results, the timing and distribution of skin lesions is often pathognomonic. Histopathologic findings characterize certain reaction patterns and provide insights on pathogenetic mechanisms. Unfortunately, skin assessment, especially invasive examinations such as biopsy, takes a back seat in severely ill patients. A literature retrieval was performed to collect information from other epidemics to counteract what has become the most frightening disease of our timeFile | Dimensione | Formato | |
---|---|---|---|
scar vaccine Acad Dermatol Venereol - 2022 - Ferreli - Transient inflammation in surgical scars following Covid‐19 mRNA vaccination.pdf Solo gestori archivio
Tipologia: versione editoriale
Dimensione 9.54 MB
Formato Adobe PDF
|
9.54 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.